1. 609. In vivo efficacy of human simulated exposures of cefiderocol (FDC) in combination with ceftazidime/avibactam (CZA) or meropenem (MEM) using in a 72 hour murine thigh infection model. (15th December 2022) Authors: Gill, Christian M; Santini, Debora; Takemura, Miki; Longshaw, Christopher M; Yamano, Yoshinori; Echols, Roger; Echols, Roger; Echols, Roger; Nicolau, David P Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. In vivo efficacy & resistance prevention of cefiderocol in combination with ceftazidime/avibactam, ampicillin/sulbactam or meropenem using human-simulated regimens versus Acinetobacter baumannii. (13th February 2023) Authors: Gill, Christian M; Santini, Debora; Takemura, Miki; Longshaw, Christopher; Yamano, Yoshinori; Echols, Roger; Nicolau, David P Journal: Journal of antimicrobial chemotherapy Issue: Volume 78:Number 4(2023) Page Start: 983 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗